Skip to main content
Client Work

MedMe Health Limited secures $C3.4 million seed financing round

Fasken
Reading Time 1 minute read
Share
  • LinkedIn

Overview

Client

MedMe Health Limited

On March 17, 2022, MedMe Health Limited ("MedMe") announced the closing of its C$3.4 million seed round financing led by the venture capital arm of Microsoft Corporation, M12, with participation from Graphite Ventures and MaRS Investment Accelerator Fund. New funding will support MedMe’s continued growth, product development and expansion into the United States.

MedMe is a virtual care and clinical services technology platform that helps pharmacies streamline workflows, build patient relationships, and diversify revenue through clinical services management.

Fasken advised MedMe with a team comprised of Will Shaw, Evan Conover, Jake Woloshyn, Alec McIlwraith-Black and Robert Marks (Articling Student).

Jurisdictions

  • Ontario
  • Canada

Team

  • Will Shaw, Partner | Co-leader, Technology, Media and Telecommunications and Co-leader, Emerging Technology, Toronto, ON, +1 416 865 4554, wshaw@fasken.com
  • Evan Conover, Associate, Toronto, ON, +1 416 943 8974, econover@fasken.com
  • Alec McIlwraith-Black, Associate, Toronto, ON, +1 416 868 3468, amcIlwraith-black@fasken.com